Second Panel on Cost-Effectiveness in Health and Medicine

The Second Panel on Cost-Effectiveness in Health and Medicine was formed in 2012 to review the current status of the field of cost-effectiveness analysis and developed a new set of recommendations. Find out more about major changes made here. (Source: The Journal of the American Medical Association, 9/13/16)

You might also be interested in:

Trump's "Buy American" Executive Order Could Raise Drug Prices 08/06/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
Matthew McHugh Appointed Director for Health Outcomes and… 02/10/2021
[Book Release] Value-Based Drug Pricing Guide on Flawed $500… 03/10/2021
New Roadmap Aims to Transform Healthcare Landscape by… 08/13/2020
Jeff Anderson Joins OPEN Health as European Lead for OPEN VIE… 06/16/2020
Scientist.com Reveals Expanded HEOR, Value, and RWE Category,… 03/23/2021